The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
FREE Daily Email Newsletter
LED Warning Lights
June 17, 2013 2:25 pm | Product Releases | CommentsThe LFH Series LED warning lights produce a high-visibility, 110 flashes-per-minute strobe beacon light suitable for virtually any industrial application: indoor or outdoor, day or night, rain or shine, hot or cold.
Globus Faces $16M Payment over Patent Dispute
June 17, 2013 1:59 pm | by The Associated Press | News | CommentsSpinal implant manufacturer Globus Medical may have to pay $16 million after a jury decided that three of its products infringed on the patents held by DePuy Synthes Products LLC, a unit of Johnson & Johnson Inc. Globus said that the jury in the U.S. District Court in Delaware made its...
BioScrip Buying Drug Infusion Company for $223M
June 17, 2013 1:42 pm | by The Associated Press | News | CommentsBioScrip Inc. plans to expand its drug infusion business with a $223 million acquisition of CarePoint, which administers drugs to patients in their homes and other locations outside of hospitals. BioScrip, of Elmsford, N.Y., provides medication infusion services such as IVs and administers...
Teva Pharma Buying MicroDose Therapeutx for $40M
June 17, 2013 1:25 pm | by The Associated Press | News | CommentsTeva Pharmaceutical Industries Ltd. said Monday that it is buying MicroDose Therapeutx for $40 million to build its pipeline of respiratory products. Teva, based in Israel, is one of the world's largest makers of generic drugs. It also makes branded medicines. As part of the deal for MicroDose,...
Perrigo Acquires Eye-Care Portfolio from Fera
June 17, 2013 11:15 am | by The Associated Press | News | CommentsPerrigo Co. said Monday that it bought the ophthalmic ointment and solution portfolio of Fera Pharmaceuticals LLC for $93 million in cash. Perrigo has been looking for an ophthalmic deal as part of its strategy to expand its presence in the niche topical medication market. The company also...
US: 'Pay to Delay' Generic Drugs Can Be illegal
June 17, 2013 10:58 am | by JESSE J. HOLLAND - Associated Press - Associated Press | News | CommentsThe Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and therefore challenged by federal officials in court. The justices voted...
J&J to Buy Aragon For at Least $650M
June 17, 2013 10:08 am | by The Associated Press | News | CommentsJohnson & Johnson said Monday that it has agreed to buy Aragon Pharmaceuticals Inc. for at least $650 million in cash, boosting its position in prostate drug development. The privately-held San Diego, company is focused on the development of drugs to treat hormonally-driven cancers. Under...
Lilly to Take Over Development of Diabetes Drug
June 17, 2013 9:16 am | by The Associated Press | News | CommentsEli Lilly and Co. will pay Canadian drug developer Transition Therapeutics Inc. $7 million and take over the development of a potential diabetes treatment heading into mid-stage clinical testing. Transition said Monday it also could receive up to $240 million in additional payments, plus...
Elan Holders OK Buyback, Vote Down Three Deals
June 17, 2013 8:43 am | News | CommentsShareholders of Irish drugmaker Elan Corp. PLC have potentially ended a takeover bid from Royalty Pharma by voting in favor of an Elan share buyback plan. The Dublin-based company's shareholders also rejected at a Monday meeting three separate deals that the Elan board has pushed instead of the Royalty takeover bid.
Can Hot Peppers Knock Out Cancer?
June 17, 2013 8:36 am | Videos | CommentsSuper hot peppers can make you sweat and tear up, but they also may fight cancer. Early research shows that capsaicin can kill cancer cells by inducing them to activate their suicide response and thus eliminating cancer from the patient.
To Ease Shortage of Organs, Grow Them in a Lab?
June 17, 2013 8:21 am | by MALCOLM RITTER,AP Science Writer | News | CommentsBy the time 10-year-old Sarah Murnaghan finally got a lung transplant last week, she'd been waiting for months, and her parents had sued to give her a better shot at surgery. Her cystic fibrosis was threatening her life, and her case spurred a debate on how to allocate donor organs. Lungs and other organs for transplant are scarce. But what if there were another way? What if you could grow a custom-made organ in a lab?
2014 Senate Democrats Firm Up Health Care Support
June 17, 2013 8:12 am | by BILL BARROW,Associated Press | News | CommentsFar from reversing course, Senate Democrats who backed President Barack Obama's health care law and now face re-election in GOP-leaning states are firming up their support for the overhaul even as Republican criticism intensifies. Mark Begich of Alaska, Mark Pryor of Arkansas, Mary Landrieu of Louisiana and Kay Hagan of North Carolina will face voters in 2014 for the first time since voting for the Affordable Care Act.
MedImmune, AstraZeneca’s Biologics Arm, and NGM Biopharmaceuticals Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity
June 17, 2013 8:06 am | News | CommentsAstraZeneca today announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM’s enteroendocrine cell (EEC) program for the treatment of type 2 diabetes and obesity.
Alabama High Court to Hear Drug Liability Arguments
June 16, 2013 11:13 am | by The Associated Press | News | CommentsThe state Supreme Court is reconsidering a decision allowing makers of name brand drugs to be held liable for injuries caused by generic versions that are made by different companies. AL.com reported Sunday that (http://bit.ly/10nzALV ) the court has announced oral arguments will be held in...
FDA Approves New Silicone Breast Implant from J&J
June 14, 2013 4:53 pm | by MATTHEW PERRONE - AP Health Writer - Associated Press | News | CommentsThe Food and Drug Administration said Friday it approved a next-generation silicone breast implant from Johnson & Johnson unit Mentor. The company's MemoryShape breast implant uses a cross-linking gel design that the FDA says is firmer than previous implants. FDA regulators approved the new...
